SUBSCRIBE   |   MY ACCOUNT   |   VIEW SHOPPING CART   |   Log In      
   CURRENT ISSUE   |   PAST ISSUES   |   SEARCH   |   SPONSORSHIPS   

 

Share on FacebookShare on TwitterShare on LinkedInEmail a link to a friend
Monday June 07, 2021

Inclined Sleepers to Be Target of House Oversight Hearing

Complimentary Access
Stories in the June 7
PRODUCT SAFETY LETTER

 

A subscription to PRODUCT SAFETY LETTER is like adding a person to your staff to dig up must-know developments like these for less than $25 a week, and you learn of hundreds every year.

 

CPSC FY2022 Appropriations Request Is $170M; Spending $185M Possible

 

Range of Stakeholders Jointly Call for Big Boost to CPSC Funds

 

Commissioners Pass Infant Sleep Products Rule 3-1

 

Inclined Sleepers to Be Target of House Oversight Hearing

 

CPSC Supervision of Firewalled Labs Gets Airing

 

NAM Seeks Open Process on Amazon Pledge Proposal

 

CPSC Staff Split on Return-to-Worksite Comfort

 

ACCC Urges Early Battery Compliance

 

EC Seeks Input on Phone/Tablet Right-to-Repair

 

Re-Charge: Battery Developments in the EU and UK

 

Briefs on youth ATVs, ATVs, pools, testing/labeling, SaferProducts.gov, and magnets plus the regular charts on recalls/corrections, standards activities, and CPSC meetings.

 

To subscribe at a $200 discount, click here.

The House Oversight and Reform Committee June 7 will question executives from Mattel and Fisher-Price about Rock 'n Play infant sleepers.

 

Focus will include "grave flaws in the U.S. consumer product safety system" and "whether Fisher-Price took any steps to ensure its product was safe…and whether the company should have recognized sooner that the Rock ‘n Play was dangerous."

 

In 2019, following widespread attention to the product (PSL, 8/19/19), the committee launched an investigation with letters to three companies that recalled inclined sleepers as well as to ASTM, JPMA, and CPSC.

 

The press release for the upcoming hearing asserts:

"The Committee’s investigation demonstrates why [CPSC] must be given more authority to regulate dangerous products, particularly those for infants and children, and how consumer protection laws can be strengthened."